Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02301325 · ClinicalTrials.gov registry record · NA
Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT02301325 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 240 participants.
The verdict
NCT02301325, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
Project 1, Study 2 will evaluate the impact of very low nicotine content cigarettes with and without transdermal nicotine on cigarettes smoked per day, nicotine exposure, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use, cigarette characteristics, cue reactivity, cardiovascular function, perceived risk and cue reactivity. The investigators will also consider differences between conditions in compliance with product use and the ability to abstain from smoking when provided a financial incentive for abstinence.
Interventions
- BEHAVIORAL Smoking research cigarettes with or without NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02301325
The ClinicalTrials.gov registry entry for NCT02301325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking research cigarettes with or without NRT is the first listed.
NCT02301325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02301325 about?
NCT02301325 is a clinical study titled "Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes". Project 1, Study 2 will evaluate the impact of very low nicotine content cigarettes with and without transdermal nicotine on cigarettes smoked per day, nicotine exposure, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to...
What is the current status of trial NCT02301325?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2014-11. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02301325?
The interventions under investigation include: Smoking research cigarettes with or without NRT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02301325?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.